Sun Pharmaceutical Industries Ltd. has announced positive results from the Phase III PIVOTAL trial for Nidlegy, showing significant improvement in Recurrence-Free Survival for patients with locally advanced melanoma.
AI Assistant
Sun Pharmaceuticals Industries Ltd
2023
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.